Program
Tin Fluorides
Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.
Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.
Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmolive | 182 open or running | phase 4since Feb 6, 2015 | Sep 26, 2008 | Sep 2027phase 4 · NCT07807397 |
| Procter and Gambleits history only | 142 open or running | phase 4since Aug 28, 2025 | Feb 28, 2012 | none ahead |
| GlaxoSmithKlineits history only | 80 open or running | phase 3since May 3, 2012 | May 3, 2012 | none ahead |
| HALEONits history only | 40 open or running | no phasesince Nov 16, 2023 | Nov 16, 2023 | none ahead |
| Church & Dwightits history only | 30 open or running | no phasesince Feb 12, 2026 | Feb 12, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Colgate Palmolive only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 1 study since Sep 26, 2008.
- Jul 15, 2014Phase 3 study in Dental PlaqueNCT02193165 · 120 enrolled · Puerto Rico
- Feb 6, 20152 phase 4 studies in Dental PlaqueNCT02366689, NCT02360995
- Feb 21, 2019Phase 3 study in Dental PlaqueNCT03852056 · 98 enrolled · China
- Jul 24, 20192 phase 4 studies in GingivitisNCT05731778, NCT04033575
- Jan 28, 2024Phase 3 study in Tooth Stain RemovalNCT06242769 · 80 enrolled · Puerto Rico
- Mar 3, 2024Phase 3 study in Dental PlaqueNCT06353165 · 100 enrolled · Thailand
- May 20, 2024Phase 3 study in Plaque, AmyloidNCT06427499 · 95 enrolled · Thailand
- Oct 29, 20252 phase 3 studiesNCT07223073, NCT07223060
- Jan 27, 2026Phase 3 study in Plaque, AmyloidNCT07398846 · 134 enrolled · United States
- Mar 4, 2026Phase 3 study in Plaque, AmyloidNCT07458464 · 95 enrolled · Thailand
- May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2NCT07619729 · 10,000 planned · United States
- Jul 26, 2026Phase 3 study in Dental HypersensitivityNCT07738198 · 116 enrolled · United States
- Sep 2, 2026Phase 4 study in Periodontal DiseasesNCT07807397 · 500 planned
- Oct 29, 2026Phase 3 study in Plaque, AmyloidNCT07917507 · 84 enrolled · Dominican Republic
Ahead
- Sep 2027Primary completion: phase 4 study in Periodontal DiseasesNCT07807397
- Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2NCT07619729
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 18 Colgate Palmolive leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07917507Plaque, Amyloid · Dominican Republic | 3 | Completed | Nov 4, 2026 | 84 |
| NCT07807397Periodontal Diseases | 4 | Not yet recruiting | Sep 2027 | 500 |
| NCT07738198Dental Hypersensitivity · United States | 3 | Completed | Dec 8, 2018 | 116 |
| NCT07619729Diabetes Mellitus, Type 2 · United States | 4 | By invitation | Jan 2, 2028 | 10,000 |
| NCT07458464Plaque, Amyloid · Thailand | 3 | Completed | Jun 28, 2026 | 95 |
| NCT07398846Plaque, Amyloid · United States | 3 | Completed | Apr 29, 2026 | 134 |
| NCT07223073Oral Malodor · Thailand | 3 | Completed | Jan 12, 2018 | 80 |
| NCT07223060Dental Calculus · Thailand | 3 | Completed | Oct 6, 2017 | 100 |
| NCT06427499Plaque, Amyloid · Thailand | 3 | Completed | Aug 5, 2024 | 95 |
| NCT06353165Dental Plaque · Thailand | 3 | Completed | Apr 12, 2023 | 100 |
| NCT06242769Tooth Stain Removal · Puerto Rico | 3 | Completed | Sep 14, 2020 | 80 |
| NCT05731778Gingivitis · Canada | 4 | Completed | Dec 22, 2020 | 26 |
| NCT04033575Gingivitis · United States | 4 | Completed | Jun 6, 2019 | 88 |
| NCT03852056Dental Plaque · China | 3 | Completed | Dec 7, 2017 | 98 |
| NCT02366689Dental Plaque · United States | 4 | Completed | Dec 2014 | 179 |
| NCT02360995Dental Plaque · United States | 4 | Completed | Aug 2014 | 129 |
| NCT02193165Dental Plaque · Puerto Rico | 3 | Completed | Aug 2014 | 120 |
| NCT00762177Oral Bacteria · United States | 3 | Completed | Sep 2008 | 24 |
How it is read
Names in the registry
- “0.454% Stannous Fluoride Dentifrice”, 8 entries
- “Stannous fluoride toothpaste”, 7 entries
- “Stannous Fluoride”, 6 entries
- “stannous fluoride toothpaste”, 5 entries
- “Stannous Fluoride Toothpaste (SnF)”, 5 entries
Conditions, from the studies’ own filings
- Gingivitis, 20 studies
- Dentin Sensitivity, 8 studies
- Dental Plaque, 7 studies
- Diabetes Mellitus, Type 2, 1 study
- Halitosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.